Shortening MDR-TB treatment: is treating more patients with fewer drugs better?

被引：4
|
作者：
Akkerman, O. W. [1 ,2 ]
Tiberi, S. [3 ,4 ]
Alffenaar, J-W. [5 ,6 ,7 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, TB Ctr Beatrixoord, Haren, Netherlands
[3] Barts Hlth NHS Trust, Dept Infect, London, England
[4] Queen Mary Univ London, Blizard Inst, London, England
[5] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia
[6] Westmead Hosp, Sydney, NSW, Australia
[7] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2021年 / 25卷 / 06期
关键词：
MULTIDRUG-RESISTANT TUBERCULOSIS; BEDAQUILINE;
D O I：
10.5588/ijtld.21.0146
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [1] A new approach to treating patients with MDR-TB?
    Iseman, MD
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (12) : 1037 - 1037
  • [2] Drugs for MDR-TB in Uganda
    Ollé-Goig, JE
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (02) : 271 - 271
  • [3] MDR-TB TREATMENT UPDATE
    Wasserman, Sean
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S49 - S49
  • [4] Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB?
    Edginton, M. E.
    Miller, D. L.
    Burney, P.
    El Sony, A. I.
    Lwilla, F. I.
    O'Brien, R.
    Roldan, M. B.
    Roldan, A.
    Srinath, S.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (09) : 1094 - 1096
  • [5] Treatment failure and MDR-TB
    Spinaci, S
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (05) : 365 - 365
  • [6] Failure predictors when treating MDR-TB
    Snene, Houda
    Daghfous, Hafaoua
    Ben Saad, Soumaya
    Ben Khelifa, Mouna
    Belhadj, Sameh
    Slim, Leila
    Tritar, Fatma
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] Healing predictors when treating MDR-TB
    Snene, Houda
    Daghfous, Hafaoua
    Ben Saad, Soumaya
    Ben Khelifa, Mouna
    Belhadj, Sameh
    Slim, Leila
    Tritar, Fatma
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [8] MDR-TB treatment outcomes in HIV positive patients
    Skrahina, Alena
    Khaliaukin, Andrei
    Hurevich, Henadz
    Zhylevich, Liudmila
    Rusovich, Valiantsin
    Belilovski, Evgeni
    Shyrayeu, Aliaksandr
    Dara, Masoud
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [9] Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
    Wai, Pyae Phyo
    Shewade, Hemant Deepak
    Kyaw, Nang Thu Thu
    Thein, Saw
    Thu, Aung Si
    Kyaw, Khine Wut Yee
    Aye, Nyein Nyein
    Phyo, Aye Mon
    Maung, Htet Myet Win
    Soe, Kyaw Thu
    Aung, Si Thu
    [J]. PLOS ONE, 2018, 13 (03):
  • [10] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    [J]. PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
12345